NEWAMSTERDAM PHARMA COMPANY's ticker is and the CUSIP is N62509117. A total of 21 filers reported holding NEWAMSTERDAM PHARMA COMPANY in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 500,333 | $1,045,696 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 462,343 | $966,297 | 0.04% |
| Affinity Asset Advisors, LLC | 37,000 | $77,330 | 0.03% |
| Exos TFP Holdings LLC | 22,273 | $46,551 | 0.02% |
| Bain Capital Life Sciences Investors, LLC | 100,000 | $209,000 | 0.02% |
| EcoR1 Capital, LLC | 66,665 | $792,647 | 0.02% |
| RA Capital Management | 333,333 | $696,666 | 0.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 92,787 | $193,925 | 0.00% |
| Westchester Capital Management, LLC | 31,189 | $65,185 | 0.00% |
| Cutler Group LLC / CA | 4,960 | $10 | 0.00% |